Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-Guerin

By Sarosdy M.F.   Manyak M.J.   Sagalowsky A.I.   Belldegrun A.   Benson M.C.   Bihrle W.   Carroll P.R.   Ellis W.J.   Hudson M.A.   Sharkey F.E.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 226-231

Elsevier

Access to resources Recommend Favorite

Tolerability of bacille Calmette-Guerin maintenance therapy for superficial bladder cancer

By Saint F.   Irani J.   Patard J.J.   Salomon L.   Hoznek A.   Zammattio S.   Debois H.   Abbou C.C.   Chopin D.K.  

Urology, Vol. 57, Iss. 5, 2001-05 ,pp. : 883-888

Elsevier

Access to resources Recommend Favorite

Intravesical bacille calmette-guerin therapy for muscle invasive bladder cancer

By Rosenbaum R.S.   Park M.-C.   Fleischmann J.  

Urology, Vol. 47, Iss. 2, 1996-02 ,pp. : 208-211

Elsevier

Access to resources Recommend Favorite

Significance of p53 overexpression in urinary bladder transitional cell carcinoma in situ before and after bacillus Calmette-Guerin treatment

By Ick K.   Schultz M.   Stout P.   Fan K.  

Urology, Vol. 49, Iss. 4, 1997-04 ,pp. : 541-547

Elsevier

Access to resources Recommend Favorite

Long-term maintenance bacille Calmette-Guerin therapy in high-grade superficial bladder cancer

By Iori F.   Di Seri M.   De Nunzio C.   Leonardo C.   Franco G.   Spalletta B.   Laurenti C.  

Urology, Vol. 59, Iss. 3, 2002-03 ,pp. : 414-418

Elsevier

Access to resources Recommend Favorite